Clinical Laserthermia Systems AB (OSTO:CLS B) ROCE % : -88.88% (As of Mar. 2025)

View and export this data going back to 2009. Start your Free Trial

What is Clinical Laserthermia Systems AB ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Clinical Laserthermia Systems AB's annualized ROCE % for the quarter that ended in Mar. 2025 was -88.88%.

Clinical Laserthermia Systems AB ROCE % Historical Data

The historical data trend for Clinical Laserthermia Systems AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clinical Laserthermia Systems AB ROCE % Chart

Clinical Laserthermia Systems AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

-497.59

-323.89

-413.69

-275.55

-86.67

Clinical Laserthermia Systems AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
ROCE %	Get a 7-Day Free Trial															-109.52	-124.65	-103.24	-56.13	-88.88

Clinical Laserthermia Systems AB ROCE % Calculation

Clinical Laserthermia Systems AB's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	-47.427	/	( ( (57.725 - 13.974)	+	(78.56 - 12.867) )	/ 2 )
	=	-47.427	/	( (43.751	+	65.693)	/ 2 )
	=	-47.427	/	54.722
	=	-86.67 %

Clinical Laserthermia Systems AB's ROCE % of for the quarter that ended in Mar. 2025 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2025 )		(Q: Dec. 2024 )		(Q: Mar. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2025 )		(Q: Dec. 2024 )		(Q: Mar. 2025 )
	=	-60.696	/	( ( (78.56 - 12.867)	+	(80.255 - 9.376) )	/ 2 )
	=	-60.696	/	( ( 65.693	+	70.879 )	/ 2 )
	=	-60.696	/	68.286
	=	-88.88 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2025) EBIT data.

Clinical Laserthermia Systems AB (OSTO:CLS B) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Clinical Laserthermia Systems AB ROCE % Related Terms

Thank you for viewing the detailed overview of Clinical Laserthermia Systems AB's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Clinical Laserthermia Systems AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Clinical Laserthermia Systems AB (OSTO:CLS B) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

LS60:Germany

Address

Scheelevagen 2, Medicon village, Lund, SWE, 223 81

Website

http://www.clinicallaser.se

Clinical Laserthermia Systems AB develops and sells single-use products used during each treatment procedure of treatment of solid tumors cancers. Its products include Thermal Therapy System, Mobile Laser Unit, Laser Applicator Non-cooled and Tissue Temp Probe.

Clinical Laserthermia Systems AB Headlines

No Headlines